Surgery Godfather
Chapter 1257 - 960: Thorny Rose_2

Chapter 1257: Chapter 960: Thorny Rose_2

Ou Lianfeng brought some local specialties to show gratitude to the doctors and nurses. He told Yang Ping that not only did he receive compensation, but also a group of people in his locality had been severely punished by the law for the matter, not just one, but a batch of people. He had not expected the issue to be dealt with so swiftly and to the satisfaction of the public.

Many of his fellow workers, like him, had become beneficiaries. Previously, they struggled with poverty and life-threatening illnesses; this time, they all received compensation. He thanked Yang Ping and Sanbo Hospital for their help.

In fact, Yang Ping also felt that he hadn’t done much, merely a small thing that a doctor should do. Objectively and truthfully giving a diagnosis was all he did, and he never imagined that it could bring about so many positive benefits, saving so many lives.

It seems that with great power comes great responsibility; this isn’t just an empty phrase. When someone’s abilities and position reach a certain level, their every move can make an impact, which can be positive or negative.

Lung transplants are currently best performed in Zhejiang, especially at Zhejiang University First Affiliated Hospital. Sanbo Hospital is still in its early stages, and the Organ Transplant Center intends to develop lung transplants, but they still need technical support from the Surgical Research Institute.

The Surgical Research Institute, as the technical cradle for Sanbo Hospital, means many technologies quickly spread to other departments. Sanbo Hospital has a strong foundation; most of its clinical doctors are Ph.D. graduates from prestigious universities. This group of young talents is the foundation for Sanbo’s leap forward; without them, it would be very difficult for Yang Ping to drive the entire hospital’s development forward.

Everyday work continues, yet research projects still see no progress, and the credits have almost run out. If no new credits come in, it would be difficult to continue the experiments. Yang Ping began to adjust his approach during this time, seriously reviewing whether his methodology might be flawed.

The K-factor protein has a significant tumor-killing effect in vitro. However, when used in experimental subjects, this effect is quite minimal. This is because the internal environment of the human body differs from the experimental environment, a problem similar to that encountered by many drugs. They perform well in the laboratory, but it is a different story inside the human body.

Some drugs can be improved through various means to achieve effects within the human body, but for others, no matter how much they are improved, they remain ineffective and consequently have to be abandoned.

The factors affecting the K-factor protein in the human body include both dynamic and static elements. These various factors interact with each other in a complex manner. The dynamism and complexity of the human body are why the field of medicine develops slower than other disciplines; the human body is just too complicated. Sometimes, when one takes a moment to study the history of medicine, every step forward was taken with great difficulty and caution, and some advancements were made amidst skepticism, persecution, and suppression.

Yang Ping continued to modify the isomers of the K-factor protein or paired it with other molecules, striving for improvements in every aspect, hoping it would perform at its best within the human body.

Pioneering innovations aren’t easy to come by; most are achieved bit by bit through the efforts of several generations—a slow, spiraling process.

System Space provides abundant resources and time but no decision-making. The decisions still rely on Yang Ping’s brain; the system is merely a powerful physical tool.

After meticulous analysis, Yang Ping finally realized that the K-factor protein, a potent small molecular protein that can induce apoptosis in tumor cells, does not exist naturally in the human body. When it acts within the body, it inevitably draws the attention of the body’s protective mechanisms, which are both intelligent and unintelligent.

Upon detecting the foreign K-factor protein, capable of causing cell death, the body’s defenses immediately become alert. However, they fail to recognize that the K-factor’s mission is to eradicate tumor cells, not normal cells. Believing that the K-factor would also destroy the body’s normal cells, the body tries everything to eliminate, hinder, and interfere with the K-factor’s function. This not only reduces the K-factor’s operational ability but also causes significant side effects to the human body. To deal with such a formidable enemy, the body must mobilize more defense resources, which, if prolonged, can cause imbalances, resulting in noticeable side effects.

This is why the K-factor works so well in vitro but is significantly less effective, even minimal, within the human body—the two environments are completely different.

It’s like a boxer who is formidable against a punch bag but can’t perform to the same level in a real boxing ring because the opponent is no longer a static target but a thinking, evasive, and attacking boxer.

Why can the K-factor not evade the human body’s defense mechanisms, whereas tumor cells can?

The K-factor is merely a small protein molecule, not an entity capable of life-like behavior. To avoid the human body’s protective mechanisms, it requires the experimenter to manually modify it, lacking self-modifying capabilities, while tumor cells, being cells, the basic units of life, modify themselves through self-evasive behaviors.

Regarding the fundamental reason for the K-factor’s failure, Yang Ping had a very clear theoretical understanding. Next, he had to think about how to make the K-factor genuinely evade the human body’s protective mechanisms and function within it.

Viruses and bacteria possess the intelligence to survive, modifying themselves to adapt to harsh environments. Yang Ping wondered if it was possible to combine the K-factor with viruses and bacteria, creating a composite entity bold enough to imagine.